The early growth response gene Egr2 (alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 2077-2090

  Fang, Feng ^a   Ooka, Kohtaro ^a   Bhattachyya, Swati ^a   Wei, Jun ^a   Wu, Minghua ^a   Du, Pan ^a   Lin, Simon ^a   Del Galdo, Francesco ^b   Feghali Bostwick, Carol A ^c   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; COLLAGEN; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 2; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; FIBROSIS; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MYOFIBROBLAST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS; UPREGULATION; WOUND HEALING;

EID: 79958167861     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.035     Document Type: Article

References (52)

1. Jimenez SA, Derk CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004, 140:37-50 (Pubitemid 38055920)
2. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med 2009, 360:1989-2003
3. Abraham DJ, Varga J: Scleroderma: from cell and molecular mechanisms to disease models. Trends Immunol 2005, 26:587-595 (Pubitemid 41726446)
4. Varga J, Pasche B: Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis. Curr Opin Rheumatol 2008, 20:720-728
5. Heldin CH, Landstrom M, Moustakas A: Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 2009, 21:166-176
6. Thiel G, Cibelli G: Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002, 193:287-292 (Pubitemid 35265949)
7. O'Donovan KJ, Tourtellotte WG, Millbrandt J, Baraban JM: The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci 1999, 22:167-173 (Pubitemid 29166785)
8. Christy B, Nathans D: DNA binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci U S A 1989, 86:8737-8741 (Pubitemid 20010299)
9. Sukhatme VP, Kartha S, Toback FG, Taub R, Hoover RG, Tsai-Morris CH: A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1987, 1:343-355 (Pubitemid 18046336)
10. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J: Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996, 273:1219-1221 (Pubitemid 26293210)
11. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J: Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci U S A 2005, 102:2596-2601 (Pubitemid 40279422)
12. Collins S, Lutz MA, Zarek PE, Anders RA, Kersh GJ, Powell JD: Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol 2008, 38:528-536
13. Basson MA, Wilson TJ, Legname GA, Sarner N, Tomlinson PD, Tybulewicz VL, Zamoyska R: Early growth response (Egr)-1 gene induction in the thymus in response to TCR ligation during early steps in positive selection is not required for CD8 lineage commitment. J Immunol 2000, 165:2444-2450 (Pubitemid 30660688)
14. Bhattacharyya S, Chen SJ, Wu M, Warner-Blankenship M, Ning H, Lakos G, Mori Y, Chang E, Nihijima C, Takehara K, Feghali-Bostwick C, Varga J: Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol 2008, 173:1085-1099
15. Chen SJ, Ning H, Ishida W, Sodin-Semrl S, Takagawa S, Mori Y, Varga J: The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J Biol Chem 2006, 281:21183-21197 (Pubitemid 44115458)
16. Wu M, Melichian DS, de la Garza M, Gruner K, Bhattacharyya S, Barr L, Nair A, Shahrara S, Sporn PH, Mustoe TA, Tourtellotte WG, Varga J: Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am J Pathol 2009, 175:1041-1055
17. Varga J, Brenner D, Phan SH: Fibrosis Research: Methods and Protocols. Totowa, NJ, Humana Press, 2005, pp xvi, 392
18. Fang F, Flegler AJ, Du P, Lin S, Clevenger CV: Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer. Am J Pathol 2009, 174:297-308
19. Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR: Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 2009, 323:651-654
20. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, Goldring MB: Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 2003, 278:17688-17700 (Pubitemid 36799371)
21. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M: Transcriptional regulation of the human alpha2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 1996, 271:26717-26723
22. Thiel G, Kaufmann K, Magin A, Lietz M, Bach K, Cramer M: The human transcriptional repressor protein NAB1: expression and biological activity. Biochim Biophys Acta 2000, 1493:289-301
23. Min BH, Foster DN, Strauch AR: The 5′-flanking region of the mouse vascular smooth muscle alpha-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J Biol Chem 1990, 265:16667-16675
24. Fang F, Antico G, Zheng J, Clevenger CV: Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter. BMC Biotechnol 2008, 8:11
25. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J: Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am J Pathol 2009, 174:519-533
26. Du P, Kibbe WA, Lin SM: nuID: a universal naming scheme of oligonucleotides for illumina, affymetrix, and other microarrays. Biol Direct 2007, 2:16
27. Du P, Kibbe WA, Lin SM: lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548 (Pubitemid 351911712)
28. Lin SM, Du P, Huber W, Kibbe WA: Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008, 36:e11
29. Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J: Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. J Invest Dermatol 2003, 121:41-50 (Pubitemid 36900453)
30. Lakos G, Takagawa S, Varga J: Animal models of scleroderma. Methods Mol Med 2004, 102:377-393
31. Galdo FD, Sotgia F, de Almeida CJ, Jasmin JF, Musick M, Lisanti MP, Jimenez SA: Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum 2008, 58:2854-2865
32. Hsu E, Feghali-Bostwick CA: Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol 2008, 172:1580-1590 (Pubitemid 351793351)
33. Wu M, Varga J: In perspective: murine models of scleroderma. Curr Rheumatol Rep 2008, 10:173-182
34. Shi-Wen X, Denton CP, McWhirter A, Bou-Gharios G, Abraham DJ, du Bois RM, Black CM: Scleroderma lung fibroblasts exhibit elevated and dysregulated type I collagen biosynthesis. Arthritis Rheum 1997, 40:1237-1244
35. Varga J, Abraham D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567 (Pubitemid 46348510)
36. Murphy TH, Worley PF, Nakabeppu Y, Christy B, Gastel J, Baraban JM: Synaptic regulation of immediate early gene expression in primary cultures of cortical neurons. J Neurochem 1991, 57:1862-1872 (Pubitemid 21922832)
37. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD, Glimcher LH: Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 2000, 12:293-300
38. Leclerc N, Noh T, Cogan J, Samarawickrama DB, Smith E, Frenkel B: Opposing effects of glucocorticoids and Wnt signaling on Krox20 and mineral deposition in osteoblast cultures. J Cell Biochem 2008, 103:1938-1951 (Pubitemid 351501923)
39. Safford M, Collins S, Lutz MA, Allen A, Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, Powell JD: Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 2005, 6:472-480 (Pubitemid 41716760)
40. Myouzen K, Kochi Y, Shimane K, Fujio K, Okamura T, Okada Y, Suzuki A, Atsumi T, Ito S, Takada K, Mimori A, Ikegawa S, Yamada R, Nakamura Y, Yamamoto K: Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. Hum Mol Genet 2010, 19:2313-2320
41. Sela U, Dayan M, Hershkoviz R, Lider O, Mozes E: A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3. J Immunol 2008, 180:1584-1591
42. Zhu B, Symonds AL, Martin JE, Kioussis D, Wraith DC, Li S, Wang P: Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J Exp Med 2008, 205:2295-2307
43. Joseph LJ, Le Beau MM, Jamieson GA Jr, Acharya S, Shows TB, Rowley JD, Sukhatme VP: Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci U S A 1988, 85:7164-7168
44. Boyle KB, Hadaschik D, Virtue S, Cawthorn WP, Ridley SH, O'Rahilly S, Siddle K: The transcription factors Egr1 and Egr2 have opposing influences on adipocyte differentiation. Cell Death Differ 2009, 16:782-789
45. Lin JX, Leonard WJ: The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol Cell Biol 1997, 17:3714-3722
46. Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, Glimcher LH: The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat Immunol 2009, 10:306-313
47. Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, Mancardi G, Charnay P: Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res 1997, 50:702-712 (Pubitemid 27518267)
48. van der Slot AJ, Zuurmond AM, Bardoel AF, Wijmenga C, Pruijs HE, Sillence DO, Brinckmann J, Abraham DJ, Black CM, Verzijl N, DeGroot J, Hanemaaijer R, TeKoppele JM, Huizinga TW, Bank RA: Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem 2003, 278:40967-40972 (Pubitemid 37280918)
49. Trojanowska M, Varga J: Molecular pathways as novel therapeutic targets in systemic sclerosis. Curr Opin Rheumatol 2007, 19:568-573 (Pubitemid 47530877)
50. Grose R, Harris BS, Cooper L, Topilko P, Martin P: Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse. Dev Dyn 2002, 223:371-378 (Pubitemid 34203081)
51. Fang F, Zheng J, Galbaugh TL, Fiorillo AA, Hjort EE, Zeng X, Clevenger CV: Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells. J Mol Endocrinol 2010, 44:319-329
52. Fang F, Rycyzyn MA, Clevenger CV: Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Endocrinology 2009, 150:1597-1606